Ventricular tachyarrhythmia and sudden cardiac death with domperidone use in Parkinson's disease

33Citations
Citations of this article
72Readers
Mendeley users who have this article in their library.

Abstract

Aim: Domperidone is preferentially used over other antiemetic agents to treat digestive symptoms in Parkinson's disease (PD). Concerns have been raised regarding an increased risk of ventricular tachyarrhythmia and sudden cardiac death (VT/SCD) associated with domperidone in the general population. However, the risk in PD is unknown. Methods: We conducted a multicentre retrospective cohort study using administrative databases from seven Canadian provinces and the UK Clinical Practice Research Datalink. Using a nested case–control analysis, we estimated the rate ratios (RRs) of VT/SCD associated with domperidone use compared to no use in patients newly-diagnosed with PD. VT/SCD events were identified using administrative medical records and vital statistics with a manual review of all potential cases. Meta-analytic methods were used to estimate overall effects across sites. Results: Among 214 962 patients with PD, 2907 cases of VT/SCD were identified during 886 581 person-years of follow-up (incidence rate 3.28 per 1000 persons per year). Current use of domperidone was associated with a non-statistically significant 22% increased risk of VT/SCD (RR 1.22; 95% CI 0.99–1.50) compared with no use. The risk was significantly elevated in those with a history of cardiovascular disease (RR 1.38; 95% CI 1.07–1.78), but not in those without (RR 1.21; 95% CI 0.81–1.81). Dose and duration of use did not affect the magnitude of the risk. Conclusion: Domperidone use may increase the risk of VT/SCD in patients with PD, particularly those with a history of cardiovascular disease. This risk may be underestimated because of imprecision in identifying VT/SCD events.

References Powered by Scopus

Epidemiology of Parkinson's disease

3303Citations
N/AReaders
Get full text

Current burden of sudden cardiac death: Multiple source surveillance versus retrospective death certificate-based review in a large U.S. community

662Citations
N/AReaders
Get full text

Diuretic therapy for hypertension and the risk of primary cardiac arrest

433Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Parkinson disease and the gut: new insights into pathogenesis and clinical relevance

134Citations
N/AReaders
Get full text

Apomorphine for Parkinson’s Disease: Efficacy and Safety of Current and New Formulations

125Citations
N/AReaders
Get full text

Cardiac abnormalities in Parkinson's disease and Parkinsonism

118Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Renoux, C., Dell’Aniello, S., Khairy, P., Marras, C., Bugden, S., Turin, T. C., … Sketris, I. S. (2016). Ventricular tachyarrhythmia and sudden cardiac death with domperidone use in Parkinson’s disease. British Journal of Clinical Pharmacology, 461–472. https://doi.org/10.1111/bcp.12964

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 21

51%

Researcher 13

32%

Professor / Associate Prof. 5

12%

Lecturer / Post doc 2

5%

Readers' Discipline

Tooltip

Medicine and Dentistry 18

55%

Pharmacology, Toxicology and Pharmaceut... 6

18%

Neuroscience 6

18%

Agricultural and Biological Sciences 3

9%

Article Metrics

Tooltip
Mentions
News Mentions: 1

Save time finding and organizing research with Mendeley

Sign up for free